Drug · DIN 02469367
PREVYMIS
240 MG/12 ML SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 20, 2017; first marketed December 20, 2017.
- Drug Identification Number (DIN)
- 02469367
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Letermovir J05AX18
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LETERMOVIR | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 1, 2017: NOC 19991New Drug Submission (NDS)
Other DINs named PREVYMIS
- DIN 02469375 · Marketed
- DIN 02469383 · Marketed
- DIN 02469405 · Cancelled Post Market